ESTUTC-5 New YorkLog in Sign up

LGVN
Longeveron Inc. Common Stock
stockNASDAQ

At CloseOct 30, 2026

1.67USD-4.571%(-0.08)80,814

Pre-marketOct 30, 2026 8:08:30 AM EDT

1.7003USD+1.814%(+0.0303)

LGVN News

Day breaks

09:15 AM EDTLongeveron Announces Engagement of Lucid Capital Markets ·

GlobeNewswire Inc.

09:15 AM EDTLongeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS) ·

GlobeNewswire Inc.

04:05 PM EDTLongeveron to Participate in Three Longevity/Aging Investment Conferences ·

GlobeNewswire Inc.

07:54 PM EDTLongeveron (LGVN) Heart Treatment Falls Short. Can a Strategic Review Preserve Value? ·

Insider Monkey

11:14 AM EDTLGVN Posts Disappointing Trial Results ·

Zacks Small Cap Research

05:27 PM EDTLongeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS) ·

GlobeNewswire Inc.